NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NHGRI E-236-1999-0-BE-24 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC BE EP 99924535.0 Expired
NHGRI E-236-1999-0-CH-25 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC CH EP 99924535.0 Expired
NHGRI E-236-1999-0-GB-31 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC GB EP 99924535.0 Expired
NHGRI E-236-1999-0-NL-36 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC NL EP 99924535.0 Expired
NHGRI E-236-1999-0-LU-35 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC LU EP 99924535.0 Expired
NHGRI E-236-1999-0-GR-32 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC GR EP 99924535.0 Expired
NHGRI E-236-1999-0-IT-34 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC IT EP 99924535.0 Expired
NHGRI E-236-1999-0-IE-33 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC IE EP 99924535.0 Expired
NHGRI E-236-1999-0-DK-27 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC DK EP 99924535.0 Expired
NHGRI E-236-1999-0-EP-06 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC EP National Stage 99924535.0 Expired
NHGRI E-236-1999-0-DE-26 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC DE EP 99924535.0 Expired
NHGRI E-236-1999-0-FI-29 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC FI EP 99924535.0 Expired
NHGRI E-236-1999-0-FR-30 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC FR EP 99924535.0 Expired
NHGRI E-236-1999-0-MX-12 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC MX National Stage PA/a/2000/011821 Expired
NHGRI E-236-1999-0-SK-21 Methods and Compositions Useful of Modulation of Angiogensis Using Tyrosine Kinase SRC SK National Stage 1811-2000 Expired
NHGRI E-236-1999-0-NO-13 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC NO National Stage 20006026 Expired
NHGRI E-236-1999-0-CA-14 Methods and Compositions Useful for Modulation of Angiogenesis Using Tyrosine Kinase SRC CA National Stage 2330025 Abandoned
NHLBI E-127-1998-0-ES-15 AAV5 VECTOR AND USES THEREOF ES EP 99926036.7 Expired
NHLBI E-127-1998-0-NL-13 AAV5 VECTOR AND USES THEREOF NL EP 99926036.7 Expired
NHLBI E-127-1998-0-GB-12 AAV5 VECTOR AND USES THEREOF GB EP 99926036.7 Expired
NHLBI E-127-1998-0-EP-06 AAV5 VECTOR AND USES THEREOF EP National Stage 99926036.7 Expired
NHLBI E-127-1998-0-IT-14 AAV5 VECTOR AND USES THEREOF IT EP 99926036.7 Expired
NHLBI E-127-1998-0-FR-11 AAV5 VECTOR AND USES THEREOF FR EP 99926036.7 Expired
NHLBI E-127-1998-0-DE-10 AAV5 VECTOR AND USES THEREOF DE EP 99926036.7 Expired
NHLBI E-127-1998-0-JP-05 AAV5 AND USES THEREOF JP National Stage 2000-550986 Expired
NHGRI E-236-1999-0-HK-09 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC HK National Stage 02102827.3 Expired
NHGRI E-236-1999-0-CN-10 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC CN National Stage 99809073.5 Expired
NHGRI E-236-1999-0-UA-20 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC UA National Stage 2000127086 Expired
NHGRI E-236-1999-0-TR-18 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC TR National Stage 105541 Expired
NHGRI E-236-1999-0-RU-08 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC RU National Stage 2000133327 Expired
NHGRI E-236-1999-0-AU-04 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC AU National Stage 41013/99 Abandoned
NHLBI E-127-1998-0-AU-03 AAV5 AND USES THEREOF AU National Stage 42205/99 Expired
NHGRI E-236-1999-0-ZA-19 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC ZA National Stage 2000/07321 Expired
NIDDK E-177-1992-1-US-01 EXPRESSION OF A HETEROLOGOUS PROTEIN C IN MAMMARY TISSUE OF TRANSGENIC ANIMALS USING A LONG WHEY ACID PROTEIN PROMOTER US CIP 09/321,831 6262336 Expired PDF
NHGRI E-236-1999-0-SG-17 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC SG National Stage 200006997-1 Expired
NIMH E-162-1998-0-PCT-02 MAMMALIAN GB2 GABAB RECEPTORS PCT PCT PCT/US1999/011869 Expired
NHLBI E-127-1998-0-PCT-02 AAV5 AND USES THEREOF PCT PCT PCT/US1999/011958 Expired
NHGRI E-236-1999-0-PCT-02 Methods and Compositions Useful of Modulation of Angiogensis Using Tyrosine Kinase SRC PCT PCT PCT/US1999/011780 Expired
NHGRI E-236-1999-0-KR-16 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC KR National Stage 10-2000-7013490 Expired
NHGRI E-236-1999-0-BR-05 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC BR National Stage PI9910787-2 Abandoned
NHGRI E-236-1999-0-HU-11 Methods and Compositions Useful of Modulation of Angiogenesis Using Tyrosine Kinase SRC HU National Stage P0102614 Expired
NCI E-250-2000-0-US-01 Immortalized Human Ear Epithelial Cell Line. US 60/136,736 Abandoned
NIMH E-089-1998-0-US-01 Two Enterocin-Producing strains Of Bacteria And their Enterocins,Both Of Which Are Lethal To Vancomycin-Resistant Enterococcus Faecium...... US 60/136,789 Abandoned
CC E-090-1999-0-US-01 Dual HDL/Total Cholesterol Test US 60/136,709 Abandoned
NIDA E-196-1999-0-US-01 cDNA Fragment T155c, From SV 40 Gene SV40 Large T, for Immortalizing Cells US 60/136,492 Abandoned
NCI E-181-1999-0-US-01 Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Virus Vector US 60/137,126 Abandoned
NCI E-139-1999-0-US-01 IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY Affinity Improvement of scFVsr ab's w/higher affinity for Mesothelin US 60/160,071 Abandoned
NCI E-054-1994-0-US-03 METHOD OF INDUCING CELL-MEDIATED PROTECTIVE IMMUNITY AGAINST HIV USING LOW DOSES OF IMMUNOGENS US CON 09/321,498 Abandoned
CC E-142-1998-0-PCT-02 Labeling DNA Plasmids with Triplex-Forming Oligonucleotides, and Methods for Assaying Distribution of DNA Plasimids in Vivo PCT PCT PCT/US1999/011511 Expired
NIDDK E-193-1999-0-US-01 1,3-Dialkylzanthine Derivative for Treatment For Asthma US 60/136,041 Abandoned